Standout Papers

Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiat... 2006 2026 2012 2019 1.1k
  1. Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer (2006)
    Robert Timmerman, Ronald C. McGarry et al. Journal of Clinical Oncology
  2. Recommendations on the Use of 18F-FDG PET in Oncology (2008)
    James Fletcher, Benjamin Djulbegović et al. Journal of Nuclear Medicine
  3. Positron Emission Tomography-Computed Tomography Standardized Uptake Values in Clinical Practice and Assessing Response to Therapy (2010)
    Paul E. Kinahan, James Fletcher Seminars in Ultrasound CT and MRI

Immediate Impact

13 from Science/Nature 57 standout
Sub-graph 1 of 22

Citing Papers

Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
100 years of the Warburg effect: A cancer metabolism endeavor
2024 Standout
2 intermediate papers

Works of James Fletcher being referenced

[68Ga]Ga-P16-093 as a PSMA-Targeted PET Radiopharmaceutical for Detection of Cancer: Initial Evaluation and Comparison with [68Ga]Ga-PSMA-11 in Prostate Cancer Patients Presenting with Biochemical Recurrence
2019
Primary and Recurrent Early Stage Laryngeal Cancer: Preliminary Results of 2-[Fluorine 18]fluoro-2-deoxy-d-glucose PET Imaging
1999

Author Peers

Author Last Decade Papers Cites
James Fletcher 1715 2127 499 990 68 4.2k
Ingemar Näslund 819 1120 308 1127 69 2.8k
Brian T. Collins 661 1605 1080 821 228 4.7k
Michael J. Seider 421 2003 266 1109 52 2.9k
Patrick W. McLaughlin 598 2259 227 1434 124 3.2k
Andrew Hope 2381 3624 1501 2006 300 7.5k
Peter D. Inskip 1549 1598 1455 360 135 8.4k
Michael Andersson 400 455 1025 480 28 3.4k
Stephen Davis 616 773 344 945 91 2.3k
William H. Moore 881 854 156 97 126 2.4k
John H. Lawrence 408 767 147 359 166 5.4k

All Works

Loading papers...

Rankless by CCL
2026